Periorbital botulinum toxin injection and lacrimal gland position
Medical hypothesis, discovery & innovation in optometry · 24.07.2026 · 7 (2) · 73-79
DOI: 10.51329/mehdioptometry248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical hypothesis, discovery & innovation in optometry, online erschienen am 24.07.2026. Verfasst von Mansooreh Jamshidian-Tehrani und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Botulinum toxin injection is the most widely performed nonsurgical procedure for upper facial rejuvenation and has an established safety profile. However, because the lacrimal gland is anatomically supported by the surrounding periorbital soft tissues, temporary muscle relaxation following periorbital botulinum toxin injection may alter its position. This prospective pilot study investigated changes in lacrimal gland position after cosmetic periorbital botulinum toxin injection using standardized ultrasonographic measurements.
Methods
This prospective pilot study enrolled eligible adults undergoing cosmetic periorbital botulinum toxin type A injection at a tertiary ophthalmic center between January 2022 and September 2024. Participants underwent standardized ophthalmic and periorbital examinations before treatment. Lacrimal gland ultrasonography was performed at baseline and two weeks after injection by a blinded radiologist in both the supine and sitting positions. Maximum axial and anteroposterior diameters of both lacrimal glands were measured bilaterally. Changes from baseline, group comparisons, and associations with demographic and clinical characteristics were evaluated.
Results
Nineteen participants (10 [52.6%] women and 9 [47.4%] men; mean [standard deviation] age, 45.3 [9.0] years) were included. Compared with baseline, lacrimal gland dimensions generally increased after periorbital botulinum toxin injection, except for a small, non-significant decrease in the axial diameter of the right lacrimal gland in the supine position (P > 0.05). Statistically significant increases in both axial and anteroposterior diameters of the right and left lacrimal glands were observed in the sitting position (all P < 0.05), whereas no significant changes were detected in the supine position (all P > 0.05). Changes in ultrasound parameters were not associated with age, sex, previous upper-eyelid blepharoplasty, or the number of crow's-feet injection points (all P > 0.05).
Conclusions
This prospective pilot study demonstrated that cosmetic periorbital botulinum toxin injection was associated with ultrasonographic changes consistent with altered position of the lacrimal gland in the sitting position, whereas no significant changes were observed in the supine position. These findings suggest that temporary relaxation of the periorbital musculature may influence lacrimal gland position. Larger prospective studies with longer follow-up and comprehensive functional assessments are warranted to verify these preliminary findings and clarify their clinical significance.
Zitieren
APA
Jamshidian-Tehrani, M., Sonbolestan, S. A., Sharif-Kashani, S., Mahmoudi, F., & Asadigandomani, H. (2026). Periorbital botulinum toxin injection and lacrimal gland position. Medical hypothesis, discovery & innovation in optometry, 7(2), 73-79. https://doi.org/10.51329/mehdioptometry248
Vancouver
Jamshidian-Tehrani M, Sonbolestan SA, Sharif-Kashani S, Mahmoudi F, Asadigandomani H. Periorbital botulinum toxin injection and lacrimal gland position. Medical hypothesis, discovery & innovation in optometry. 2026;7(2):73-79. doi:10.51329/mehdioptometry248
BibTeX
@article{JamshidianTehrani2026,
author = {Jamshidian-Tehrani, Mansooreh and Sonbolestan, Seyed Ali and Sharif-Kashani, Shervin and Mahmoudi, Fatemeh and Asadigandomani, Hassan},
title = {Periorbital botulinum toxin injection and lacrimal gland position},
journal = {Medical hypothesis, discovery & innovation in optometry},
year = {2026},
volume = {7},
number = {2},
pages = {73--79},
doi = {10.51329/mehdioptometry248}
}
EUVIMED